REPEAT Study - Resistance to ErythroPoietin Effectiveness Algorithm Trial

NCT00319150 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped New evidence and trouble recruiting

Conditions

Kidney Failure, Chronic
Drug Resistance

Interventions

DRUG: erythropoietin

Sponsor

Queen's University

Collaborators

[object Object]